Opioid use is increasing in pregnancy as well as in the general population. A “Five things to know about …” practice article on opioid disuse in pregnancy in CMAJ (Canadian Medical Association Journal) provides information on how to manage this vulnerable population.
- In parallel with the opioid epidemic in the general population, opioid use and associated opioid use disorders in pregnancy are rising.
- Guidelines support universal screening for drug use, including opioids, by prenatal care providers.
- Opioid agonist therapy is the standard of care for opioid use disorders in pregnancy, along with counseling and mental health supports. Pregnant women with opioid use disorder should be offered timely access to opioid agonist therapy.
- Neonatal opioid withdrawal syndrome is best managed by keeping mothers and infants together after delivery. Breastfeeding should be encouraged in women who are stable on opioid agonist therapy, for whom there are no concerns about ongoing drug use.
- Ongoing support in the postpartum period is essential, as women with opioid use disorders are at increased risk of fatal overdose in the first year postpartum.
Reference: “Opioid use disorder in pregnancy” (PDF) by Anshula Ambasta MD MPH and Mary Malebranche MD MA, 23 September 2019, CMAJ.
Be the first to comment on "5 Critical Things to Know About Opioid Use Disorder in Pregnancy"